ArticleExperimental hematology2021

The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib.

Matthew T Villaume et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.